Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
editorial
. 2002 Nov 13;10(14):971–976. doi: 10.1016/0264-410X(92)90105-S

Prophylaxis: the foundation for our future progress

RE Spier 1
PMCID: PMC7131814  PMID: 1471427

The content is available as a PDF (762.8 KB).

References

  • 1.Baron J. 3rd edn. Vol. 1. Henry Colburn Publisher; London: 1838. pp. 103–137. (The Life of Edward Jenner). [Google Scholar]
  • 2.Wilson G.S. The Hazards of Immunization. Athlone Press; London: 1967. p. 323. [Google Scholar]
  • 3.Peetermans J. Production, quality control and characterization of an inactivated hepatitis A vaccine. Vaccine. 1992;10(Supplement 1):S99–S101. doi: 10.1016/0264-410x(92)90557-z. [DOI] [PubMed] [Google Scholar]
  • 4.Prince A.M. Hepatitis B Virus: active and passive immunization. In: Cryz S.J. Jr, editor. Vaccines and Immunotherapy. Pergamon; Oxford: 1991. pp. 256–270. [Google Scholar]
  • 5.Patarroyo M.E., Amador R., Clavijo P., Moreno A., Guzman F., Romero P. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 1988;332:158–161. doi: 10.1038/332158a0. [DOI] [PubMed] [Google Scholar]
  • 6.Schorr J., Knapp B., Hundt E., Kupper H.A., Aman E. Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. Vaccine. 1991;9:675. doi: 10.1016/0264-410x(91)90194-b. [DOI] [PubMed] [Google Scholar]
  • 7.Burke K.L., Dunn G., Ferguson M., Minor P.D., Almond J.W. Antigen chimaeras of poliovirus as potential new vaccines. Nature. 1988;332:81–82. doi: 10.1038/332081a0. [DOI] [PubMed] [Google Scholar]
  • 8.Bowsley P. Financial Times. 25 June 1992 and colleagues. (Work quoted.) [Google Scholar]
  • 9.McCullough K.C., Spier R.E. Monoclonal Antibodies in Biotechnology: Theoretical and Practical Aspects. Cambridge University Press; Cambridge: 1991. pp. 265–315. [Google Scholar]
  • 10.Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 1992;257:238–241. doi: 10.1126/science.1352912. [DOI] [PubMed] [Google Scholar]
  • 11.Talwar G.P., editor. Contraception research for today and the nineties. 3rd edn. Vol. 1. Springer Verlag; New York: 1988. Progress in birth control vaccines; p. 401. (Progress in Vaccinology). [Google Scholar]
  • 12.Burns K.N. Diseases of farm animals. In: Cooke G.W., editor. Agricultural Research 1931–1981. Agricultural Research Council; London: 1981. p. 270. [Google Scholar]
  • 13.Dev. Biol. Stand. 1977;35 [Google Scholar]
  • 14.Bachrach H.L. Viruses and Environment. Academic Press; London: 1978. Foot-and-mouth disease: worldwide impact and control measures; pp. 299–310. [Google Scholar]
  • 15.Spier R.E. Production of veterinary vaccines. In: Mizrahi A., van Wezel A.L., editors. 3rd edn. Vol. 2. Alan R. Liss; New York: 1983. pp. 34–61. (Advances in Biotechnological Processes). [Google Scholar]
  • 16.Langley D., Spier R.E. Is a vaccine against AIDS possible? Vaccine. 1988;6:3–5. [PubMed] [Google Scholar]
  • 17.Meyaard L., Otto S.A., Jonker R.R., Mijnster M.J., Keet R.P.M., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 1992;257:217–219. doi: 10.1126/science.1352911. [DOI] [PubMed] [Google Scholar]
  • 18.Brown P. How does HIV cause AIDS? New Scientist. 18 July 1992:31–35. [Google Scholar]
  • 19.Edington S.M. Is an AIDS vaccine possible? Bio/technology. 1992;10:768–771. doi: 10.1038/nbt0792-768. [DOI] [PubMed] [Google Scholar]

Articles from Vaccine are provided here courtesy of Elsevier

RESOURCES